Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx

Status unconfirmed · Phase 2

Conditions studied: Precancerous Condition

In brief

RATIONALE: Vaccines made from papilloma virus cells may make the body build an immune response to and kill papilloma cells. PURPOSE: Phase II trial to study the effectiveness of papilloma virus vaccine in treating young patients with recurrent papilloma of the larynx.

Key facts

Study ID

NCT00002454

Run by

University of Medicine and Dentistry of New Jersey

Starts

1971-12-01

Last updated by the study team

2011-07-26

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• New Jersey Medical School — Newark, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.